Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr 17:8:53.
doi: 10.3389/fnsys.2014.00053. eCollection 2014.

Attitudes toward pharmacological cognitive enhancement-a review

Affiliations
Review

Attitudes toward pharmacological cognitive enhancement-a review

Kimberly J Schelle et al. Front Syst Neurosci. .

Abstract

A primary means for the augmentation of cognitive brain functions is "pharmacological cognitive enhancement" (PCE). The term usually refers to the off-label use of medical substances to improve mental performance in healthy individuals. With the final aim to advance the normative debate taking place on that topic, several empirical studies have been conducted to assess the attitudes toward PCE in the public, i.e., in groups outside of the academic debate. In this review, we provide an overview of the 40 empirical studies published so far, reporting both their methodology and results. Overall, we find that several concerns about the use of PCE are prevalent in the public. These concerns largely match those discussed in the normative academic debate. We present our findings structured around the three most common concerns: medical safety, coercion, and fairness. Fairness is divided into three subthemes: equality of opportunity, honesty, and authenticity. Attitudes regarding some concerns are coherent across studies (e.g., coercion), whereas for others we find mixed results (e.g., authenticity). Moreover, we find differences in how specific groups-such as users, nonusers, students, parents, and health care providers-perceive PCE: a coherent finding is that nonusers display more concerns regarding medical safety and fairness than users. We discuss potential psychological explanations for these differences.

Keywords: authenticity; brain function augmentation; coercion; cognitive enhancement; fairness; medical safety; neuroenhancement; smart drugs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. *. Aikins R. D. (2011). Academic performance enhancement: a qualitative study of the perceptions and habits of prescription stimulant-using college students. J. Coll. Stud. Dev. 52, 560–576 10.1353/csd.2011.0064 - DOI
    1. *. Asscher E. C. A., Schermer M. (2013). Wish-fulfilling medicine in practice: the opinions and arguments of lay people. J. Med. Ethics. [Epub ahead of print]. 10.1136/medethics-2013-101480 - DOI - PubMed
    1. Bachman J. G., Johnson L. D., O'Malley P. M. (1998). Explaining recent increases in students' marijuana use: impacts of perceived risks and disapproval, 1976 through 1996. Am. J. Public Health 88, 887–892 10.2105/AJPH.88.6.887 - DOI - PMC - PubMed
    1. *. Ball N., Wolbring G. (2014). Cognitive enhancement: perceptions among parents of children with disabilities. Neuroethics 1–20 10.1007/s12152-014-9201-8 [Epub ahead of print]. - DOI - PMC - PubMed
    1. *. Banjo O. C., Nadler R., Reiner P. B. (2010). Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount. PLoS ONE 5:e14322 10.1371/journal.pone.0014322 - DOI - PMC - PubMed

LinkOut - more resources